Alzheimer’s Disease Neuroimaging Initiative (ADNI 3) (Optimizing Canadian Neuropathology Infrastructure in the Alzheimer’s Disease Neuroimaging Initiative (ADNI 3))
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit:
Memorial Deadline: Inquire with RGCS
External Deadline: Tuesday 22nd, August 2017
Description
This funding opportunity is a directed grant to add a coordinated and centralized brain donation and brain banking system (neuropathology infrastructure) for the Canadian Alzheimer’s disease Neuroimaging Initiative (ADNI) participants in order to optimize Canada’s participation in the ADNI initiative.
ADNI is a United States National Institutes of Health-led initiative with a goal to develop accurate means to identify who may be at risk for Alzheimer Disease (AD). ADNI also aims to accurately track progression of the disease and devise tests to measure the effectiveness of potential interventions. The ADNI study includes scientists at fifty research centers in the US and four in Canada.
There are currently 32 neuropathology cores in the US supporting ADNI studies. Brain autopsy programs have become a central feature, but have been completely missing from the Canadian dementia research scene. Funding from CIHR will support this type of work in Canada.
Funds Available
CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to the grant received as a result of this funding opportunity.
- The total amount available for this funding opportunity is $1,065,000, enough to fund one grant. The maximum amount available per year is $213,000 per year for up to five years.
Visit CIHR’s website for more program details.